NCT00895232View on ClinicalTrials.gov

Iron Sucrose In The Treatment of Restless Legs Syndrome: Safety of Three Dose Regimens as Evaluated by Clinical Assessments

PHASE2CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

November 30, 2003

Primary Completion Date

August 31, 2005

Study Completion Date

November 30, 2005

Conditions
Restless Legs Syndrome
Interventions
DRUG

Cohort I

DRUG

Cohort II

DRUG

Cohort III

Sponsors
All Listed Sponsors
lead

American Regent, Inc.

INDUSTRY